For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Cara Therapeutics Inc (NASDAQ: CARA) was $0.31 for the day, up 5.94% from the previous closing price of $0.29. In other words, the price has increased by $5.94 from its previous closing price. On the day, 0.64 million shares were traded. CARA stock price reached its highest trading level at $0.315 during the session, while it also had its lowest trading level at $0.2768.
Ratios:
Our analysis of CARA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.48 and its Current Ratio is at 4.59. In the meantime, Its Debt-to-Equity ratio is 4.07 whereas as Long-Term Debt/Eq ratio is at 4.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on June 13, 2024, Downgraded its rating to Hold and sets its target price to $1 from $6 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 01 ’24 when Posner Christopher sold 4,149 shares for $0.35 per share. The transaction valued at 1,452 led to the insider holds 172,436 shares of the business.
Posner Christopher sold 3,936 shares of CARA for $2,952 on May 02 ’24. The PRESIDENT AND CEO now owns 176,585 shares after completing the transaction at $0.75 per share. On Apr 05 ’24, another insider, Goncalves Joana, who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,753 shares for $0.83 each. As a result, the insider received 2,285 and left with 53,365 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CARA now has a Market Capitalization of 16728213 and an Enterprise Value of 7274225. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.52 while its Price-to-Book (P/B) ratio in mrq is 1.44. Its current Enterprise Value per Revenue stands at 0.662 whereas that against EBITDA is -0.069.
Stock Price History:
Over the past 52 weeks, CARA has reached a high of $1.86, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -7.61%, while the 200-Day Moving Average is calculated to be -48.26%.
Shares Statistics:
CARA traded an average of 657.98K shares per day over the past three months and 389570 shares per day over the past ten days. A total of 54.48M shares are outstanding, with a floating share count of 45.76M. Insiders hold about 16.57% of the company’s shares, while institutions hold 32.32% stake in the company. Shares short for CARA as of 1726185600 were 1207225 with a Short Ratio of 1.83, compared to 1723680000 on 1458611. Therefore, it implies a Short% of Shares Outstanding of 1207225 and a Short% of Float of 2.56.
